Toronto Centre Solving Cell Manufacturing Challenges to Benefit Patients and Global Industry

TORONTO and MARLBOROUGH, Mass., June 2 (Korea Bizwire) — With Health Canada and the Food and Drug Administration beginning to approve and reimburse cell and gene therapies in significant numbers, the demand for cell and viral vector manufacturing will continue to grow. Consequently, the industrialization challenges associated with the variability of cell and gene therapies, [...]